Cargando…

Suppression of Hepatic PPARα in Primary Biliary Cholangitis Is Modulated by miR-155

Background: PPARα is a ligand-activated transcription factor that shows protective effects against metabolic disorders, inflammation and apoptosis. Primary biliary cholangitis and primary sclerosing cholangitis result in the intrahepatic accumulation of bile acids that leads to liver dysfunction and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adamowicz, Monika, Kempinska-Podhorodecka, Agnieszka, Abramczyk, Joanna, Banales, Jesus M., Milkiewicz, Piotr, Milkiewicz, Malgorzata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496720/ https://www.ncbi.nlm.nih.gov/pubmed/36139455 http://dx.doi.org/10.3390/cells11182880

Ejemplares similares

Effect of Low Testosterone Levels on the Expression of Proliferator-Activated Receptor Alpha in Female Patients with Primary Biliary Cholangitis
por: Kempińska-Podhorodecka, Agnieszka, et al.
Publicado: (2023)

Modulation of Mismatch Repair and the SOCS1/p53 Axis by microRNA-155 in the Colon of Patients with Primary Sclerosing Cholangitis
por: Adamowicz, Monika, et al.
Publicado: (2022)

The Role of hsa-miR-125b-5p Interaction with S1P/Ceramide Axis in the Potential Development of Inflammation-Associated Colon Cancer in Primary Sclerosing Cholangitis
por: Abramczyk, Joanna, et al.
Publicado: (2023)

Role of miR-506 in ulcerative colitis associated with primary sclerosing cholangitis
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2021)

Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2017)

Enhanced expression of miR-21 and miR-150 is a feature of anti-mitochondrial antibody-negative primary biliary cholangitis
por: Wasik, Urszula, et al.
Publicado: (2020)

Protection against oxidative stress mediated by the Nrf2/Keap1 axis is impaired in Primary Biliary Cholangitis
por: Wasik, Urszula, et al.
Publicado: (2017)

Melatonin Protects Cholangiocytes from Oxidative Stress-Induced Proapoptotic and Proinflammatory Stimuli via miR-132 and miR-34
por: Ostrycharz, Ewa, et al.
Publicado: (2020)

ApaI polymorphism of vitamin D receptor affects health-related quality of life in patients with primary sclerosing cholangitis
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2017)

Oncomir MicroRNA-346 Is Upregulated in Colons of Patients With Primary Sclerosing Cholangitis
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2020)

Vitamin-D Receptor-Gene Polymorphisms Affect Quality of Life in Patients with Autoimmune Liver Diseases
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2020)

TRAF1-C5 Affects Quality of Life in Patients with Primary Biliary Cirrhosis
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2013)

Impaired Hepatic Adaptation to Chronic Cholestasis induced by Primary Sclerosing Cholangitis
por: Milkiewicz, Malgorzata, et al.
Publicado: (2016)

Ursodeoxycholic Acid Influences the Expression of p27(kip1) but Not FoxO1 in Patients with Non-Cirrhotic Primary Biliary Cirrhosis
por: Milkiewicz, Malgorzata, et al.
Publicado: (2014)

Expression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the disease
por: Wunsch, Ewa, et al.
Publicado: (2015)

The Association between SOCS1−1656G>A Polymorphism, Insulin Resistance and Obesity in Nonalcoholic Fatty Liver Disease (NAFLD) Patients
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2019)

TRAF1 Gene Polymorphism Correlates with the Titre of Gp210 Antibody in Patients with Primary Biliary Cirrhosis
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2012)

Vitamin D Receptor Polymorphisms Predispose to Primary Biliary Cirrhosis and Severity of the Disease in Polish Population
por: Kempińska-Podhorecka, Agnieszka, et al.
Publicado: (2012)

Leisure time physical activity and health-related behaviours after liver transplantation: a prospective, single-centre study
por: Kotarska, Katarzyna, et al.
Publicado: (2015)

Polymorphisms of IL12RB2 May Affect the Natural History of Primary Biliary Cholangitis: A Single Centre Study
por: Wasik, Urszula, et al.
Publicado: (2017)

p-STAT3 is a PDC-E2 interacting partner in human cholangiocytes and hepatocytes with potential pathobiological implications
por: Kilanczyk, Ewa, et al.
Publicado: (2021)

DHEA Protects Human Cholangiocytes and Hepatocytes against Apoptosis and Oxidative Stress
por: Kilanczyk, Ewa, et al.
Publicado: (2022)

Factors Affecting Health-Related Quality of Life and Physical Activity after Liver Transplantation for Autoimmune and Nonautoimmune Liver Diseases: A Prospective, Single Centre Study
por: Kotarska, Katarzyna, et al.
Publicado: (2014)

Primary biliary cholangitis: pathogenic mechanisms
por: Prieto, Jesús, et al.
Publicado: (2021)

Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXR
por: Wunsch, Ewa, et al.
Publicado: (2015)

A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients
por: Paziewska, Agnieszka, et al.
Publicado: (2017)

PR3-ANCAs Detected by Third-Generation ELISA Predicts Severe Disease and Poor Survival in Primary Sclerosing Cholangitis
por: Lopens, Steffi, et al.
Publicado: (2022)

A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients
por: Kruk, Beata, et al.
Publicado: (2022)

Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies
por: Milkiewicz, Malgorzata, et al.
Publicado: (2012)

Profiling Circulating and Urinary Bile Acids in Patients with Biliary Obstruction before and after Biliary Stenting
por: Trottier, Jocelyn, et al.
Publicado: (2011)

Primary Sclerosing Cholangitis With Features of Autoimmune Hepatitis: Exploring the Global Variation in Management
por: Milkiewicz, Piotr, et al.
Publicado: (2020)

PPAR agonists for the treatment of primary biliary cholangitis: Old and new tales
por: Colapietro, Francesca, et al.
Publicado: (2023)

Relation of the C/T-13910 LCT Polymorphism with Body Composition Measures and Their Modulation by Dairy Products in a Caucasian Men
por: Popadowska, Agnieszka, et al.
Publicado: (2021)

Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis
por: Wunsch, Ewa, et al.
Publicado: (2020)

Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study
por: Koziarska, Dorota, et al.
Publicado: (2013)

Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitis
por: Schramm, Christoph, et al.
Publicado: (2022)

PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC
por: Kruk, Beata, et al.
Publicado: (2018)

The search for the Holy Grail: autoantigenic targets in primary sclerosing cholangitis associated with disease phenotype and neoplasia
por: Lopens, Steffi, et al.
Publicado: (2020)

Role of Glucuronidation for Hepatic Detoxification and Urinary Elimination of Toxic Bile Acids during Biliary Obstruction
por: Perreault, Martin, et al.
Publicado: (2013)

Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22
por: Smyk, Daniel S., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_fi43ums2mmok29am5dom70ro2n